Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
6(60%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_1
2
20%
Ph not_applicable
3
30%
Ph phase_3
1
10%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

10

all time

Status Distribution
Active(6)
Completed(4)

Detailed Status

Recruiting5
Completed4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
6
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (33.3%)
Phase 31 (16.7%)
N/A3 (50.0%)

Trials by Status

recruiting550%
active_not_recruiting110%
completed440%

Recent Activity

6 active trials
Showing 5 of 10
recruitingnot_applicable

Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia

NCT07707245
active_not_recruitingphase_3

Adjuvant Avelumab in Merkel Cell Cancer

NCT03271372
recruiting

Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters

NCT06716242
completedphase_1

Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)

NCT04477512
recruitingnot_applicable

CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors

NCT06727383
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07707245Not Applicable

Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia

Recruiting
NCT03271372Phase 3

Adjuvant Avelumab in Merkel Cell Cancer

Active Not Recruiting
NCT06716242

Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters

Recruiting
NCT04477512Phase 1

Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)

Completed
NCT06727383Not Applicable

CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors

Recruiting
NCT06281262

Selected Immunological Indicators and Microbiota in Patients With Premature Birth and Preeclampsia

Recruiting
NCT04088422

Cell Free DNA in Mature B-cell Lymphoma

Recruiting
NCT03526666

Ascorbic Acid Levels in MDS, AML, and CMML Patients

Completed
NCT03970434Phase 1

Drug Concentration of Metformin According to Sampling Method

Completed
NCT02801942Not Applicable

Immune Profile in Subjects With New Onset Type 1 Diabetes

Completed

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10